The β-Cell in Diabetes: From Molecular Genetics to Clinical Research

Pancreatic insulin secretion rates can be accurately derived by mathematical deconvolution of peripheral C-peptide concentrations either by using individual C-peptide kinetic parameters obtained by analysis of the decay curve of biosynthetic human C-peptide or by using published group parameters with appropriate adjustments for age and degree of obesity. Since the cross-reactivity of proinsulin and related peptides is low (< 10%) in many C-peptide assays, this experimental approach avoids the spurious increase in insulin immunoreactivity resulting from cross-reactivity with proinsulin and related peptides in the insulin assay. Application of this technique has demonstrated that the phenotypic expression of β-cell dysfunction differs in subjects with different genetic mechanisms of non-insulin-dependent diabetes mellitus (NIDDM). Subjects who have maturity-onset diabetes of the young (MODY) due to mutations in the glucokinase gene demonstrate different patterns of altered insulin secretion when compared with subjects who have mutations in the MODY1 gene on chromosome 20. Glucokinase mutations affect the ability of the β-cell to detect and respond to small increases in glucose above the basal level. However, compensatory mechanisms operative in vivo, which include a priming effect of glucose on insulin secretion, limit the severity of the observed insulin secretory defect, resulting in a generally mild clinical course in these subjects. In contrast, mutations in the MODY1 gene are associated with an inability to increase insulin secretion as the plasma glucose concentration increases above 7–8 mmol/l and the normal priming effect of glucose on insulin secretion is lost. These characteristics of the dose-response relationships between glucose and insulin secretion result in a more severe degree of hyperglycemia than observed in subjects with glucokinase mutations, and these subjects more frequently need insulin treatment. These alterations are evident in prediabetic subjects with normal glucose levels who carry the MODY1 mutation, suggesting that defective β-cell function is the primary pathogenetic defect in the diabetic syndrome in these subjects. Studies performed in the classic form of NIDDM demonstrate that subjects with mild glucose intolerance and normal fasting glucose concentrations and glycosylated hemoglobin levels consistently demonstrate defective β-cell function. These results are consistent with studies in the Zucker diabetic fatty rat, an animal model of NIDDM in which prediabetic animals demonstrate extensive alterations in expression of multiple genes involved in the regulation of insulin secretion. It thus appears that abnormal β-cell function is present at a relatively early stage in the evolution of NIDDM, even before the onset of overt hyperglycemia.

[1]  L. Groop,et al.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[2]  B. Metzger,et al.  Prepregnancy Weight and Antepartum Insulin Secretion Predict Glucose Tolerance Five Years After Gestational Diabetes Mellitus , 1993, Diabetes Care.

[3]  W. Sheu,et al.  Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. , 1993, The Journal of clinical endocrinology and metabolism.

[4]  H. Lithell,et al.  Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. , 1991, BMJ.

[5]  A. Hattersley,et al.  Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Sturis,et al.  Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. , 1994, The American journal of physiology.

[7]  R. Bergman Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[8]  S. Seino,et al.  Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. , 1993, The Journal of biological chemistry.

[9]  R. Casamitjana,et al.  Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. , 1983, The Journal of clinical endocrinology and metabolism.

[10]  P. Bennett,et al.  Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  D. Steiner,et al.  The metabolism of proinsulin and insulin by the liver. , 1972, The Journal of clinical investigation.

[12]  K. Osei,et al.  Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM , 1991, Diabetes Care.

[13]  K. Alberti,et al.  Metabolic abnormalities in children of non-insulin dependent diabetics. , 1986, British medical journal.

[14]  J. Halter,et al.  Maturity-onset diabetes of the young. , 1994, Life sciences.

[15]  J. Field,et al.  Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. , 1973, The Journal of clinical investigation.

[16]  R. DeFronzo The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[17]  A. Hattersley,et al.  Linkage of type 2 diabetes to the glucokinase gene , 1992, The Lancet.

[18]  Stefan Thor,et al.  Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo-and a Cys–His domain , 1990, Nature.

[19]  H. Luthman,et al.  Glucose Potentiation of Arginine-Induced Insulin Secretion is Impaired in Subjects With a Glucokinase Glu256Lys Mutation , 1994, Diabetes.

[20]  B H Frank,et al.  Quantitative study of insulin secretion and clearance in normal and obese subjects. , 1988, The Journal of clinical investigation.

[21]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[22]  R. Turner,et al.  Brief, Irregular Oscillations of Basal Plasma Insulin and Glucose Concentrations in Diabetic Man , 1981, Diabetes.

[23]  J. Leahy,et al.  Abnormal Insulin Secretion in a Streptozocin Model of Diabetes: Effects of Insulin Treatment , 1985, Diabetes.

[24]  J. de Vente,et al.  Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). , 1991, The American journal of physiology.

[25]  R. DeFronzo,et al.  Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. , 1987, The Journal of clinical investigation.

[26]  R. Gross,et al.  Amplification of Insulin Secretion by Lipid Messengers , 1993, Diabetes.

[27]  K. Polonsky,et al.  In vivo pulsatility of pancreatic islet peptides. , 1986, The American journal of physiology.

[28]  J. Sturis,et al.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[29]  S. Moran,et al.  Sequence of rat mitochondrial glycerol-3-phosphate dehydrogenase cDNA. Evidence for EF-hand calcium-binding domains. , 1994, The Journal of biological chemistry.

[30]  S. Price,et al.  The Determinants of Insulin Extraction in the Isolated Perfused Rat Liver* , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[31]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[32]  D. Steiner,et al.  Sequence and functional expression in Xenopus oocytes of a human insulinoma and islet potassium channel. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  V. Mohan,et al.  Decreased Insulin Sensitivity in Offspring Whose Parents Both Have Type 2 Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[34]  K. Polonsky,et al.  Reduction of Insulin Clearance During Hyperglycemic Clamp: Dose-Response Study in Normal Humans , 1988, Diabetes.

[35]  R. Turner,et al.  Pulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery , 1983, Diabetes.

[36]  M. Byrne,et al.  Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[37]  S. Metz The Pancreatic Islet as Rubik's Cube: Is Phospholipid Hydrolysis a piece of the Puzzle? , 1991, Diabetes.

[38]  E. Bonora,et al.  Decreased hepatic insulin extraction in subjects with mild glucose intolerance. , 1983, Metabolism: clinical and experimental.

[39]  E. Mosekilde,et al.  Compensation in Pancreatic β-Cell Function in Subjects With Glucokinase Mutations , 1994, Diabetes.

[40]  K. Clément,et al.  Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young , 1992, The Lancet.

[41]  A. Vaag,et al.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. , 1994, The Journal of clinical investigation.

[42]  R. Mueller,et al.  Splanchnic Insulin Dynamics and Secretion Pulsatilities in Abdominal Obesity , 1994, Diabetes.

[43]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[44]  F. Matschinsky,et al.  Pancreatic islet glucose metabolism and regulation of insulin secretion. , 1986, Diabetes/metabolism reviews.

[45]  F. Matschinsky,et al.  Adaptation of Glycolytic Enzymes: Glucose Use and Insulin Release in Rat Pancreatic Islets During Fasting and Refeeding , 1981, Diabetes.

[46]  J. Leahy,et al.  Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. , 1988, The Journal of clinical investigation.

[47]  S. Perrin,et al.  Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[49]  B. Rn,et al.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. , 1989 .

[50]  J. Halter,et al.  Altered Insulin Secretory Responses to Glucose in Subjects with a Mutation in the MODY1 Gene on Chromosome 20 , 1995, Diabetes.

[51]  G. Reaven Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[52]  W. Zawalich Modulation of Insulin Secretion From β-Cells by Phosphoinositide-Derived Second-Messenger Molecules , 1988, Diabetes.

[53]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[54]  A. Rubenstein,et al.  Circulating proinsulin in patients with maturity onset diabetes. , 1977, The American journal of medicine.

[55]  B. Portha,et al.  Insulin Treatment Improves Glucose-Induced Insulin Release in Rats With NIDDM Induced by Streptozocin , 1987, Diabetes.

[56]  K. Polonsky,et al.  Expression of Calcium Channel mRNAs in Rat Pancreatic Islets and Downregulation After Glucose Infusion , 1993, Diabetes.

[57]  P. Gorden,et al.  Glucose intolerance with hypokalemia: an increased proportion of circulating proinsulin-like component. , 1972, The Journal of clinical endocrinology and metabolism.

[58]  E. Verdin,et al.  Similar Metabolic Effects of Pulsatile Versus Continuous Human Insulin Delivery During Euglycemic, Hyperinsulinemic Glucose Clamp in Normal Man , 1984, Diabetes.

[59]  K. Clément,et al.  Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. , 1994, The Journal of clinical investigation.

[60]  K. Polonsky,et al.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[61]  G. Reaven,et al.  Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. , 1989, The Journal of clinical endocrinology and metabolism.

[62]  H. Kehlet,et al.  Decreased insulin removal contributes to hyperinsulinemia in obesity. , 1981, The Journal of clinical endocrinology and metabolism.

[63]  E. Mosekilde,et al.  Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. , 1991, The American journal of physiology.

[64]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[65]  A. Kuznetsov,et al.  Defective glucose-dependent endoplasmic reticulum Ca2+ sequestration in diabetic mouse islets of Langerhans. , 1994, The Journal of biological chemistry.

[66]  D. Kelley,et al.  Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.

[67]  A. E. Boyd Sulfonylurea Receptors, Ion Channels, and Fruit Flies , 1988, Diabetes.

[68]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[69]  J. Beckmann,et al.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.

[70]  M. J. MacDonald,et al.  Elusive Proximal Signals of β-Cells for Insulin Secretion , 1990, Diabetes.

[71]  K. Polonsky,et al.  Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. , 1982, The Journal of clinical investigation.

[72]  S. Seino,et al.  Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. DeFronzo,et al.  The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.

[74]  E. Seaquist,et al.  G Proteins and Modulation of Insulin Secretion , 1991, Diabetes.

[75]  A J Scheen,et al.  24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations. , 1995, The Journal of clinical investigation.

[76]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[77]  Yoshihiro Kubo,et al.  Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel , 1993, Nature.

[78]  M. L. Le Beau,et al.  Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA. , 1994, Molecular pharmacology.

[79]  D. Porte,et al.  Islet Function and Insulin Sensitivity in the Non‐diabetic Offspring of Conjugal Type 2 Diabetic Patients , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[80]  S. Fajans Scope and Heterogeneous Nature of MODY , 1990, Diabetes Care.

[81]  R. Hamman,et al.  The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus , 1985, Diabetes.

[82]  J. H. Johnson,et al.  Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[83]  J. Halter,et al.  Abnormal Insulin Secretion, Not Insulin Resistance, Is the Genetic or Primary Defect of MODY in the RW Pedigree , 1994, Diabetes.

[84]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[85]  P. J. Randle,et al.  Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. , 1964, The Biochemical journal.

[86]  K. Polonsky,et al.  Reduced levels of messenger ribonucleic acid for calcium channel, glucose transporter-2, and glucokinase are associated with alterations in insulin secretion in fasted rats. , 1994, Endocrinology.

[87]  M. Stoffel,et al.  Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[89]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[90]  J. Leahy Natural History of β-Cell Dysfunction in NIDDM , 1990, Diabetes Care.

[91]  S. Seino,et al.  Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. , 1992, Molecular endocrinology.

[92]  W. Waldhäusl,et al.  Efficacy of Pulsatile Versus Continuous Insulin Administration on Hepatic Glucose Production and Glucose Utilization in Type I Diabetic Humans , 1986, Diabetes.

[93]  A. Vaag,et al.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[94]  G. Paolisso,et al.  Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. , 1991, The Journal of clinical endocrinology and metabolism.

[95]  R N Bergman,et al.  Insulin sensitivity and B‐cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes , 1991, American journal of obstetrics and gynecology.

[96]  W. Duckworth,et al.  Direct measurement of plasma proinsulin in normal and diabetic subjects. , 1972, The American journal of medicine.

[97]  J. Sturis,et al.  Entrainment of pulsatile insulin secretion by oscillatory glucose infusion. , 1991, The Journal of clinical investigation.

[98]  J. Clark,et al.  The Diabetic Zucker Fatty Rat , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[99]  N J Cox,et al.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[100]  J. Field,et al.  Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs. , 1975, The American journal of physiology.

[101]  M. Byrne,et al.  Insulin secretion and clearance during low-dose graded glucose infusion. , 1995, The American journal of physiology.

[102]  D. Steiner,et al.  The new enzymology of precursor processing endoproteases. , 1992, The Journal of biological chemistry.

[103]  K. Polonsky,et al.  C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations , 1984, Diabetes.